Is Liotinib a Targeted Drug?

Liotinib is a targeted therapeutic agent that exerts its anticancer effects primarily by inhibiting specific abnormal proteins or signaling pathways within tumor cells, thereby achieving precise cancer treatment outcomes. Unlike traditional chemotherapeutic drugs, targeted agents can act more selectively on tumor-associated molecular targets, minimizing damage to normal cells.